We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Role of prostacyclin in the cardiovascular response to thromboxane A2.
- Authors
Cheng, Yan; Austin, Sandra C; Rocca, Bianca; Koller, Beverly H; Coffman, Thomas M; Grosser, Tilo; Lawson, John A; FitzGerald, Garret A
- Abstract
Thromboxane (Tx) A2 is a vasoconstrictor and platelet agonist. Aspirin affords cardioprotection through inhibition of TxA2 formation by platelet cyclooxygenase (COX-1). Prostacyclin (PGI2) is a vasodilator that inhibits platelet function. Here we show that injury-induced vascular proliferation and platelet activation are enhanced in mice that are genetically deficient in the PGI2 receptor (IP) but are depressed in mice genetically deficient in the TxA2 receptor (TP) or treated with a TP antagonist. The augmented response to vascular injury was abolished in mice deficient in both receptors. Thus, PGI2 modulates platelet-vascular interactions in vivo and specifically limits the response to TxA2. This interplay may help explain the adverse cardiovascular effects associated with selective COX-2 inhibitors, which, unlike aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs), inhibit PGI2 but not TxA2.
- Publication
Science (New York, N.Y.), 2002, Vol 296, Issue 5567, p539
- ISSN
1095-9203
- Publication type
Journal Article
- DOI
10.1126/science.1068711